Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Page 3

Ring circles $117m series B
UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.
PsiQuantum crosses off $450m in funding
PsiQuantum has become the first unicorn in Imec.xpand’s portfolio as it fetched a valuation of more than $3bn.
Investors assist Artios in $153m series C
IP Group is among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.
SoftBank finds Ethos with $100m investment
SoftBank’s Vision Fund 2 has invested at a $2.7bn valuation, taking the Stanford-backed life insurance platform developer’s overall funding to over $400m.
Form Energy recharges in $200m round
ArcelorMittal led a series D round for the rechargeable battery developer spun out of MIT.
OpenSea captures $100m at $1.5bn valuation
The NFT marketplace, which counts Stanford-StartX Fund as an investor, has raised series B funding led by Andreessen Horowitz.
Go1 inputs $200m in series D funding
The Oxford-backed corporate education resource provider’s overall funding now stands at more than $280m.
Nature’s Fynd feeds on $350m series C
Several corporates helped the Montana State University-backed microbial protein developer take its total funding above $500m.
Wugen wraps up $172m series B
WUSTL spinout Wugen has collected $172m in a series B round to progress its pipeline targeting several cancer indications.
Prime Medicine presents $315m in funding
The gene editing technology developer is the latest spinout emerging out of the lab of David Liu at Broad Institute.

test reg

Login